167 related articles for article (PubMed ID: 22435962)
1. Off-label use of antipsychotic medications in Medicaid.
Leslie DL; Rosenheck R
Am J Manag Care; 2012 Mar; 18(3):e109-17. PubMed ID: 22435962
[TBL] [Abstract][Full Text] [Related]
2. Off-label use of antipsychotic medications in the department of Veterans Affairs health care system.
Leslie DL; Mohamed S; Rosenheck RA
Psychiatr Serv; 2009 Sep; 60(9):1175-81. PubMed ID: 19723731
[TBL] [Abstract][Full Text] [Related]
3. Use of administrative data to identify off-label use of second-generation antipsychotics in a Medicaid population.
Hartung DM; Middleton L; McFarland BH; Haxby DG; McDonagh MS; McConnell KJ
Psychiatr Serv; 2013 Dec; 64(12):1236-42. PubMed ID: 23999754
[TBL] [Abstract][Full Text] [Related]
4. Trends in and Predictors of Long-Term Antipsychotic Polypharmacy Use Among Ohio Medicaid Patients with Schizophrenia, 2008-2014.
Fontanella CA; Hiance-Steelesmith DL; Guirgis H; Campo JV
Psychiatr Serv; 2018 Sep; 69(9):1015-1020. PubMed ID: 29962308
[TBL] [Abstract][Full Text] [Related]
5. Trends in off-label use of antipsychotic medications among Texas Medicaid children and adolescents from 2013 to 2016.
Chen S; Barner JC; Cho E
J Manag Care Spec Pharm; 2021 Aug; 27(8):1035-1045. PubMed ID: 34337993
[No Abstract] [Full Text] [Related]
6. Diagnoses associated with use of atypical antipsychotics in a commercial health plan: a claims database analysis.
Citrome L; Kalsekar I; Guo Z; Laubmeier K; Hebden T
Clin Ther; 2013 Dec; 35(12):1867-75. PubMed ID: 24119767
[TBL] [Abstract][Full Text] [Related]
7. Risk of arrest in persons with schizophrenia and bipolar disorder in a Florida Medicaid program: the role of atypical antipsychotics, conventional neuroleptics, and routine outpatient behavioral health services.
Van Dorn RA; Andel R; Boaz TL; Desmarais SL; Chandler K; Becker MA; Howe A
J Clin Psychiatry; 2011 Apr; 72(4):502-8. PubMed ID: 21527125
[TBL] [Abstract][Full Text] [Related]
8. Concurrent mental health therapy among medicaid-enrolled youths starting antipsychotic medications.
Harris E; Sorbero M; Kogan JN; Schuster J; Stein BD
Psychiatr Serv; 2012 Apr; 63(4):351-6. PubMed ID: 22337007
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
[TBL] [Abstract][Full Text] [Related]
10. Prescribing of antipsychotic medication in a medicaid population: use of polytherapy and off-label dosages.
Kogut SJ; Yam F; Dufresne R
J Manag Care Pharm; 2005; 11(1):17-24. PubMed ID: 15667230
[TBL] [Abstract][Full Text] [Related]
11. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
12. Off-label antipsychotic use patterns among Texas Medicaid adults 2013-2016.
Chen S; Barner JC; Cho E
J Comp Eff Res; 2021 Oct; 10(14):1045-1053. PubMed ID: 34525842
[No Abstract] [Full Text] [Related]
13. Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims.
Lambert BL; Chou CH; Chang KY; Tafesse E; Carson W
Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):417-25. PubMed ID: 15786516
[TBL] [Abstract][Full Text] [Related]
14. Off-label use of antidepressant, anticonvulsant, and antipsychotic medications among Georgia medicaid enrollees in 2001.
Chen H; Reeves JH; Fincham JE; Kennedy WK; Dorfman JH; Martin BC
J Clin Psychiatry; 2006 Jun; 67(6):972-82. PubMed ID: 16848658
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Testing for Adults in a State Medicaid Program Receiving Antipsychotics: Remaining Barriers to Achieving Population Health Prevention Goals.
Morrato EH; Campagna EJ; Brewer SE; Dickinson LM; Thomas DS; Miller BF; Dearing J; Druss BG; Lindrooth RC
JAMA Psychiatry; 2016 Jul; 73(7):721-30. PubMed ID: 27167755
[TBL] [Abstract][Full Text] [Related]
16. Patterns of atypical antipsychotic subtherapeutic dosing among Oregon Medicaid patients.
Hartung DM; Wisdom JP; Pollack DA; Hamer AM; Haxby DG; Middleton L; McFarland BH
J Clin Psychiatry; 2008 Oct; 69(10):1540-7. PubMed ID: 19192436
[TBL] [Abstract][Full Text] [Related]
17. Patterns and predictors of off-label prescription of psychiatric drugs.
Vijay A; Becker JE; Ross JS
PLoS One; 2018; 13(7):e0198363. PubMed ID: 30024873
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of medicaid beneficiaries with schizophrenia receiving clozapine only or antipsychotic combinations.
Velligan DI; Carroll C; Lage MJ; Fairman K
Psychiatr Serv; 2015 Feb; 66(2):127-33. PubMed ID: 25321616
[TBL] [Abstract][Full Text] [Related]
19. The Impact of a State Medicaid Peer-Review Authorization Program on Pediatric Use of Antipsychotic Medications.
Pennap D; Burcu M; Safer DJ; Zito JM
Psychiatr Serv; 2018 Mar; 69(3):293-299. PubMed ID: 29137557
[TBL] [Abstract][Full Text] [Related]
20. Off-Label Prescribing of Antipsychotics in Adults, Children and Elderly Individuals: A Systematic Review of Recent Prescription Trends.
Carton L; Cottencin O; Lapeyre-Mestre M; Geoffroy PA; Favre J; Simon N; Bordet R; Rolland B
Curr Pharm Des; 2015; 21(23):3280-97. PubMed ID: 26088115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
